Adirondack Research & Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $204K | Hold |
1,890
| – | – | 0.25% | 97 |
|
|
2021
Q2 | $213K | Hold |
1,890
| – | – | 0.25% | 91 |
|
|
2021
Q1 | $205K | Hold |
1,890
| – | – | 0.24% | 88 |
|
|
2020
Q4 | $203K | Buy |
+1,890
| New | +$203K | 0.28% | 76 |
|
|
2018
Q1 | – | Sell |
-4,100
| Closed | -$397K | – | 113 |
|
|
2017
Q4 | $397K | Sell |
4,100
-2,200
| -35% | -$213K | 0.16% | 95 |
|
|
2017
Q3 | $560K | Hold |
6,300
| – | – | 0.22% | 77 |
|
|
2017
Q2 | $457K | Hold |
6,300
| – | – | 0.18% | 84 |
|
|
2017
Q1 | $411K | Hold |
6,300
| – | – | 0.15% | 94 |
|
|
2016
Q4 | $395K | Hold |
6,300
| – | – | 0.13% | 91 |
|
|
2016
Q3 | $397K | Hold |
6,300
| – | – | 0.14% | 92 |
|
|
2016
Q2 | $390K | Hold |
6,300
| – | – | 0.15% | 92 |
|
|
2016
Q1 | $360K | Hold |
6,300
| – | – | 0.13% | 91 |
|
|
2015
Q4 | $373K | Hold |
6,300
| – | – | 0.14% | 85 |
|
|
2015
Q3 | $343K | Hold |
6,300
| – | – | 0.13% | 91 |
|
|
2015
Q2 | $423K | Sell |
6,300
-125
| -2% | -$8.39K | 0.16% | 84 |
|
|
2015
Q1 | $376K | Hold |
6,425
| – | – | 0.15% | 84 |
|
|
2014
Q4 | $420K | Sell |
6,425
-50
| -0.8% | -$3.27K | 0.16% | 85 |
|
|
2014
Q3 | $374K | Hold |
6,475
| – | – | 0.14% | 90 |
|
|
2014
Q2 | $365K | Hold |
6,475
| – | – | 0.12% | 93 |
|
|
2014
Q1 | $333K | Hold |
6,475
| – | – | 0.13% | 93 |
|
|
2013
Q4 | $342K | Hold |
6,475
| – | – | 0.17% | 89 |
|
|
2013
Q3 | $290K | Sell |
6,475
-200
| -3% | -$8.96K | 0.17% | 90 |
|
|
2013
Q2 | $276K | Buy |
+6,675
| New | +$276K | 0.21% | 90 |
|